In the last trading session, 1.61 million Mind Medicine Inc (NASDAQ:MNMD) shares changed hands as the company’s beta touched 2.69. With the company’s per share price at $4.89 changed hands at -$0.54 or -9.94% during last session, the market valuation stood at $368.55M. MNMD’s last price was a discount, traded about -132.31% off its 52-week high of $11.36. The share price had its 52-week low at $4.83, which suggests the last value was 1.23% up since then. When we look at Mind Medicine Inc’s average trading volume, we note the 10-day average is 1.6 million shares, with the 3-month average coming to 2.01 million.
Analysts gave the Mind Medicine Inc (MNMD) stock a consensus recommendation rating of Buy. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MNMD as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Mind Medicine Inc’s EPS for the current quarter is expected to be -0.37.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD was in red as seen at the end of in last trading. With action -11.73%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -29.74%, with the 5-day performance at -11.73% in the red. However, in the 30-day time frame, Mind Medicine Inc (NASDAQ:MNMD) is -22.38% down. Looking at the short shares, we see there were 11.37 million shares sold at short interest cover period of 4.92 days.
The consensus price target for the stock as assigned by Wall Street analysts is 16, meaning bulls need an upside of 69.44% from its current market value. According to analyst projections, MNMD’s forecast low is 16 with 16 as the target high. To hit the forecast high, the stock’s price needs a -227.2% plunge from its current level, while the stock would need to soar -227.2% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 10.40%. The 2025 estimates are for Mind Medicine Inc earnings to increase by 36.90%.
MNMD Dividends
Mind Medicine Inc is expected to release its next quarterly earnings report on 2025-Mar-05.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.49% of Mind Medicine Inc shares while 55.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 56.64%. There are 55.79% institutions holding the Mind Medicine Inc stock share, with COMMODORE CAPITAL LP the top institutional holder. As of 2024-06-30, the company held 9.9369% of the shares, roughly 7.15 million MNMD shares worth $51.52 million.
DEEP TRACK CAPITAL, LP holds the second largest percentage of outstanding shares, with 8.4879% or 6.1 million shares worth $44.01 million as of 2024-06-30.
Among Mutual Funds, the top two as of Feb 28, 2025 were iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 2.09 shares estimated at $10.21 million under it, the former controlled 2.77% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.31% of the shares, roughly 988.95 shares worth around $4.84 million.
